Eagle Pharmaceuticals Reports Second Quarter 2022 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. FIX
9. TSCO
10. BE

Go back to Eagle Pharmaceuticals Reports Second Quarter 2022 Results

Eagle Pharmaceuticals (EGRX) Misses Q2 EPS by $1.80

August 9, 2022 7:26 AM EDT

Eagle Pharmaceuticals (NASDAQ: EGRX) reported Q2 EPS of $1.56, $1.80 worse than the analyst estimate of $3.36. Revenue for the quarter came in at $74.1 million versus the consensus estimate of $116.95 million.

For earnings history and earnings-related data on Eagle Pharmaceuticals (EGRX) click here.

... More